Cantero Therapeutics, a BridgeBio company
1 clinical trials · Sponsor
◉ Watch Cantero Therapeutics, a BridgeBio company
| Record | Firm | Date |
|---|---|---|
| A Study of BBP-711 (ORF-229) in Healthy Adult Volunteers (NCT04876924) | Cantero Therapeutics, a BridgeBio company | 2021-04-29 |
Track Cantero Therapeutics, a BridgeBio company automatically
Every clearance here is in the API, with alerts when new ones post.